A hospital-based real-world analysis examining immediate blood pressure and heart rate changes after initiating a mineralocorticoid receptor antagonist in diabetic kidney disease.
Key Takeaways
- Finerenone was primarily prescribed to patients with average grade III albuminuria
- Blood pressure decreased significantly after initiation, often within 24 to 48 hours
- Heart rate remained stable during early treatment while background antihypertensives stayed unchanged